Alexei Bogdanov to Antineoplastic Agents
This is a "connection" page, showing publications Alexei Bogdanov has written about Antineoplastic Agents.
Connection Strength
0.389
-
Reichardt W, Hu-Lowe D, Torres D, Weissleder R, Bogdanov A. Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model. Neoplasia. 2005 Sep; 7(9):847-53.
Score: 0.170
-
Marecos E, Weissleder R, Bogdanov A. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model. Bioconjug Chem. 1998 Mar-Apr; 9(2):184-91.
Score: 0.101
-
Bogdanov AA, Martin C, Bogdanova AV, Brady TJ, Weissleder R. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. Bioconjug Chem. 1996 Jan-Feb; 7(1):144-9.
Score: 0.087
-
Simonova M, Wall A, Weissleder R, Bogdanov A. Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cells. Cancer Res. 2000 Dec 01; 60(23):6656-62.
Score: 0.031